Antitrust, Infringement Claims Split In Cardizem Suit
A federal judge has agreed to stay parts of discovery and bifurcate the trial in a patent infringement suit over hypertension drug Cardizem, weeks after defendant Sun Pharmaceutical Industries Ltd. introduced...To view the full article, register now.
Already a subscriber? Click here to view full article